Yasmine Wasfi
Known title: Chief Medical OfficerCIK: 0002092127
Associated companies
Transaction History
| SVRA | ▼ Sell | Tax Withholding | 21,992 | $140K | 12/4/2025 | View on chart |
| SVRA | ▲ Buy | Grant | 35,000 | $0 | 10/20/2025 | View on chart |
| SVRA | ▼ Sell | Tax Withholding | 21,992 | $140K | 12/4/2025 | View on chart |
| SVRA | ▲ Buy | Grant | 35,000 | $0 | 10/20/2025 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
Savara Stock Mentioned Among Gainers in Market Roundup
Savara Inc. was included in a recent market roundup highlighting stocks that moved higher on Wednesday. The company's shares are currently trading near a key support level, which may have contributed to the short-term price movement noted in the report. This mention reflects general market activity rather than a specific corporate announcement.
Savara Stock Mentioned Among Gainers in Market Roundup. Savara Inc. was included in a recent market roundup highlighting stocks that moved higher on Wednesday. The company's shares are currently trading near a key support level, which may have contributed to the short-term price movement noted in the report. This mention reflects general market activity rather than a specific corporate announcement.